Takeda Pharmaceutical Co Ltd (LTS:0A87)
$ 15.67 (0%) Market Cap: 50.04 Bil Enterprise Value: 78.08 Bil PE Ratio: 0 PB Ratio: 1.15 GF Score: 73/100

Q3 2026 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript

Jan 29, 2026 / 10:30AM GMT
Release Date Price: $15.89

Jan 29, 2026 / 10:30AM GMT
Presentation
Jan 29, 2026 / 10:30AM GMT

=====================
Corporate Participants
=====================
* Christopher O'Reilly
Takeda Pharmaceutical Co Ltd - Global Head of Investor Relations
* Christophe Weber
Takeda Pharmaceutical Co Ltd - President, Chief Executive Officer, Representative Director
* Milano Furuta
Takeda Pharmaceutical Co Ltd - Chief Financial Officer, Director
* Andrew Plump
Takeda Pharmaceutical Co Ltd - President of Research & Development, Vice President of Subsidiary, Director
* Julie Kim
Takeda Pharmaceutical Co Ltd - President of the US Business Unit, US Country Head & Interim Head of Global Portfolio Division

=====================
Conference Call Participants
=====================
* Shinichiro Muraoka
Morgan Stanley - Analyst
* Hidemaru Yamaguchi
Citi Infrastructure Investments LLC - Analyst
* Stephen Barker
Jefferies LLC - Analyst
* Hiroyuki Matsubara
Nomura Securities International Inc - Analyst
*

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot